What is ColoWrap?
ColoWrap, Inc. is dedicated to advancing gastrointestinal (GI) procedures through its proprietary colonoscopy compression device. The companys flagship product, ColoWrap, is engineered to enhance the quality of colonoscopies by reducing cecal intubation times and mitigating risks associated with traditional endoscopy. By addressing the physical demands on clinicians and improving patient comfort, ColoWrap seeks to set a new standard in endoscopic practices. The company also emphasizes comprehensive training and safety programs to support the adoption of its technology and ensure optimal patient outcomes.
How much funding has ColoWrap raised?
ColoWrap has raised a total of $149K across 1 funding round:
Debt
$149K
Debt (2021): $149K with participation from PPP
Key Investors in ColoWrap
PPP
Public-Private Partnership
What's next for ColoWrap?
With the recent strategic investment, ColoWrap is poised for significant expansion and further development of its innovative medical technology. The substantial capital infusion, reflected in the $149K total financing, suggests a late-stage funding round aimed at scaling operations, increasing market penetration, and potentially broadening its product portfolio. This backing will likely enable ColoWrap to accelerate its go-to-market strategy, enhance manufacturing capabilities, and invest further in research and development to maintain its competitive edge in the evolving landscape of gastrointestinal diagnostics and treatments. The focus on improving safety and efficiency in colonoscopies positions ColoWrap as a key player in enhancing patient care and protecting healthcare professionals.
See full ColoWrap company page
